BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 10921915)

  • 1. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction.
    Igarashi J; Michel T
    J Biol Chem; 2000 Oct; 275(41):32363-70. PubMed ID: 10921915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells.
    Igarashi J; Bernier SG; Michel T
    J Biol Chem; 2001 Apr; 276(15):12420-6. PubMed ID: 11278407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways.
    Igarashi J; Michel T
    J Biol Chem; 2001 Sep; 276(39):36281-8. PubMed ID: 11470796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells.
    Gonzalez E; Nagiel A; Lin AJ; Golan DE; Michel T
    J Biol Chem; 2004 Sep; 279(39):40659-69. PubMed ID: 15292187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold.
    Li H; Brodsky S; Basco M; Romanov V; De Angelis DA; Goligorsky MS
    Circ Res; 2001 Feb; 88(2):229-36. PubMed ID: 11157677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells.
    Ryu Y; Takuwa N; Sugimoto N; Sakurada S; Usui S; Okamoto H; Matsui O; Takuwa Y
    Circ Res; 2002 Feb; 90(3):325-32. PubMed ID: 11861422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase.
    Kou R; Igarashi J; Michel T
    Biochemistry; 2002 Apr; 41(15):4982-8. PubMed ID: 11939794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration.
    Kluk MJ; Hla T
    Circ Res; 2001 Sep; 89(6):496-502. PubMed ID: 11557736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells.
    Sato K; Ui M; Okajima F
    Brain Res Mol Brain Res; 2000 Dec; 85(1-2):151-60. PubMed ID: 11146117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3.
    Kimura T; Watanabe T; Sato K; Kon J; Tomura H; Tamama K; Kuwabara A; Kanda T; Kobayashi I; Ohta H; Ui M; Okajima F
    Biochem J; 2000 May; 348 Pt 1(Pt 1):71-6. PubMed ID: 10794715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelial nitric-oxide synthase-caveolin regulatory cycle.
    Feron O; Saldana F; Michel JB; Michel T
    J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.
    Dessy C; Kelly RA; Balligand JL; Feron O
    EMBO J; 2000 Aug; 19(16):4272-80. PubMed ID: 10944110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors.
    Malek RL; Toman RE; Edsall LC; Wong S; Chiu J; Letterle CA; Van Brocklyn JR; Milstien S; Spiegel S; Lee NH
    J Biol Chem; 2001 Feb; 276(8):5692-9. PubMed ID: 11069896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
    Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T
    J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization.
    Kohno T; Wada A; Igarashi Y
    FASEB J; 2002 Jul; 16(9):983-92. PubMed ID: 12087059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.
    Feron O; Belhassen L; Kobzik L; Smith TW; Kelly RA; Michel T
    J Biol Chem; 1996 Sep; 271(37):22810-4. PubMed ID: 8798458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1.
    Liu CH; Thangada S; Lee MJ; Van Brocklyn JR; Spiegel S; Hla T
    Mol Biol Cell; 1999 Apr; 10(4):1179-90. PubMed ID: 10198065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.
    Okamoto H; Takuwa N; Yokomizo T; Sugimoto N; Sakurada S; Shigematsu H; Takuwa Y
    Mol Cell Biol; 2000 Dec; 20(24):9247-61. PubMed ID: 11094076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase.
    Gonzalez E; Kou R; Lin AJ; Golan DE; Michel T
    J Biol Chem; 2002 Oct; 277(42):39554-60. PubMed ID: 12189156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.